Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Maravai LifeSciences Holdings Inc at Robert W Baird Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 04:50PM GMT
Release Date Price: $46.71 (+2.55%)
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

All right. Great. Thanks, everyone, for joining us today. I'm Catherine Schulte. I cover Life Sciences & Diagnostics here at Baird. We're very excited to have Maravai presenting here today. And from the company, we have Kevin Herde, CFO; and Deb Hart, Senior Director of Investor Relations.

Before we begin, just a reminder to refer to Baird's website and our published research were important disclosures about what we're discussing today. As far as the agenda, Kevin is going to give us a quick full review of the company, and then we'll jump to the Q&A. (Operator Instructions) So with that, Kevin, I will hand it over to you.

Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - VP & CFO

Perfect. Thanks, Catherine. Thanks for having us at the conference. We appreciate it. So I'm just going to do a brief overview of Maravai LifeSciences, then we'll get on to some questions. So just a quick disclaimer, we may use some forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot